Application YC di Serinus Biosciences

Summer 2022Active

Serinus Biosciences ha partecipato a Y Combinator nel batch Summer 2022 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2022
Settore: HealthcareTherapeutics
Dimensione team: 6
Stato: Active
Lanciata: 2022

Founder

Adam YaariFounder/CEO
Maxwell ShermanFounder/CTO

Cosa fa Serinus Biosciences

Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.

Application YC di Serinus Biosciences, ricostruita

Domanda per Y Combinator

Serinus Biosciences, batch Summer 2022. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Serinus Biosciences

Describe what your company does in 50 characters or less.

Combinations therapy by rational design

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI platform that designs combination therapies to overcome cancer treatment resistance. Our system uses decades of system biology knowledge to model how cancer evolves escape routes to therapies, allowing us to propose molecule combinations that are more effective and safer. The output is explainable, letting researchers and clinicians understand why the selected combinations work.

Where do you live now, and where would the company be based after YC?

We live and operate in New York, NY, USA, and plan to keep the company based here after YC.

Explain your decision regarding location.

New York is a biotech and healthcare innovation hub with access to top academic partners and talent. Staying here lets us collaborate closely with our scientific advisors and prospective customers while benefiting from YC's remote-friendly approach.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Serinus Biosciences?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Serinus Biosciences (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Serinus Biosciences si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Serinus Biosciences?

Serinus Biosciences apparteneva al batch Summer 2022 di Y Combinator.

Chi ha fondato Serinus Biosciences?

Serinus Biosciences è stato fondato da Adam Yaari, Maxwell Sherman.

Cosa fa Serinus Biosciences?

Combinations therapy by rational design

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Serinus Biosciences, e di ogni altro batch YC, è in YC Insights.